首页> 美国卫生研究院文献>Clinical Cardiology >Critical pathways in the emergency department improve treatment modalities for patients with ST‐elevation myocardial infarction in a European hospital
【2h】

Critical pathways in the emergency department improve treatment modalities for patients with ST‐elevation myocardial infarction in a European hospital

机译:一家欧洲医院急诊科的关键途径改善了ST抬高型心肌梗死患者的治疗方式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:The use of protocols for patients with ST‐elevation myocardial infarction (MI) is growing, but no definite conclusion regarding the value of critical pathways in Europe has been drawn. Hypothesis:The aim of this study was to investigate the impact of critical pathway on processes of care and outcome for patients presenting to the emergency department (ED) of a large urban European hospital because of possible ST‐elevation MI. Methods:Critical pathways for management of acute chest pain at our ED were developed in 1998 and have been revised every year. Accordingly, the records of all patients referred in 1997 to the ED because of chest pain (before pathway implementation) and in 2001 (after last pathway revision) were reviewed. An ST‐elevation MI was diagnosed at ED in 520 of 5,066 (10.3%) patients with chest pain in 1997, and in 452 of 4,843 (9.3%) patients with chest pain in 2001. Patients were managed according to the ED cardiologists' decisions in 1997, whereas they entered the pathways for ST‐elevation MI in 2001, with predefined criteria for diagnosis, thrombolysis, percutaneous coronary intervention, and admission to the coronary care unit. Results:Comparison of treatment modalities disclosed that more patients were given thrombolysis in 1997 (49 vs. 16%, p < 0.05), whereas in 2001 more patients were sent to primary angioplasty (63 vs. 11%, p < 0.05). Also in 2001, patients more often received aspirin (90 vs. 61%, p < 0.05) and intravenous beta blockers (60 vs. 35%, p < 0.05) soon after arrival at the ED. Comparison between 1997 and 2001 revealed that admission rates to the coronary care unit (69 vs. 78%, NS) and cardiac wards were similar (19 vs. 10%, NS). Conversely, compared with 1997, patients hospitalized in 2001 had a shorter length of stay (12 ± 5 vs. 18 ± 6 days, p < 0.05), as well as fewer major adverse coronary events (21 vs. 30%, p < 0.05) and lower all‐cause in‐hospital mortality (12 vs. 20%, p < 0.05). The quality of care indicators improved with time, as door‐to‐electrocardiogram interval (10 ± 6 vs. 19 ± 9 min, p < 0.05), door‐to‐needle time (25 ± 10 vs. 35 ± 10 min, p < 0.05), and door‐to‐balloon interval (70 ± 15 vs. 99 ± 20 min, p < 0.05) were shorter in 2001 than in 1997. Conclusions:A critical pathway for ST‐elevation MI at the ED increases the use of evidence‐based treatment strategies and improves outcome and quality of care of patients presenting to a European hospital because of acute chest pain.
机译:背景:ST抬高型心肌梗死(MI)患者使用该方案的人数正在增长,但尚未得出关于欧洲关键途径的价值的明确结论。假设:这项研究的目的是调查可能的ST抬高MI导致关键途径对就诊于欧洲一家大型城市医院急诊室(ED)的患者的护理过程和结果的影响。方法:1998年制定了急诊科治疗急性胸痛的关键途径,并每年进行修订。因此,回顾了1997年因胸痛(在实施途径之前)和2001年(在上次途径修订之后)转诊至急诊室的所有患者的记录。 1997年,在5 066名(10.3%)胸痛患者中有520例在ED诊断为ST抬高型心梗,2001年在4843例(9.3%)胸痛患者中有452例被诊断为ED。根据ED心脏病专家的决定进行治疗在1997年,他们进入了ST抬高MI的途径,并在2001年确定了诊断,溶栓,经皮冠状动脉介入治疗和进入冠心病监护病房的预定义标准。结果:治疗方式的比较显示,1997年有更多的患者接受了溶栓治疗(49比16%,p <0.05),而2001年有更多的患者接受了原发性血管成形术(63比11%,p <0.05)。同样在2001年,到达急诊科后不久,患者更经常接受阿司匹林(90比61%,p <0.05)和静脉注射β受体阻滞剂(60比35%,p <0.05)。 1997年和2001年的比较显示,冠心病监护病房的入院率(69%对78%,NS)和心脏病房相似(19%对10%,NS)。相反,与1997年相比,2001年住院的患者住院时间短(12±5比18±6天,p <0.05),并且主要的不良冠状动脉事件更少(21 vs. 30%,p <0.05) )并降低全因医院死亡率(12%vs. 20%,p <0.05)。随时间的推移,护理质量随着时间的延长而改善,如门心电图间隔(10±6比19±9分钟,p <0.05),门对针时间(25±10比35±10分钟,p <0.05),门到气球间隔(70±15比99±20分钟,p <0.05)在2001年比1997年短。结论:急诊室ST抬高MI的关键途径增加了使用基于证据的治疗策略,并改善因急性胸痛而就诊于欧洲医院的患者的结局和护理质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号